See today's BioWorld Science
To read the full story, subscribe or sign in.
Cardiovascular

China's CDE clears IND for Help's iPS cell-derived cardiomyocyte therapy for ischemic heart failure

Jan. 31, 2023
Help Therapeutics Co. Ltd. has received IND approval from China's Center for Drug Evaluation (CDE) for HiCM-188.
BioWorld Science Stem cells Cardiovascular China IND